That my brother and his wife are back on FB because they no longer will be fact checked tells you everything they care about truth.

FDA Approves Ensartinib for Locally Advanced or Metastatic ALK+ NSCLC The FDA has approved ensartinib for patients with ALK+ locally advanced or metastatic NSCLC who have not previously received an ALK inhibitor.

ICYMI! Good news for my ALK+ friends

www.onclive.com/view/fda-app...

The trade-off between accelerated cancer drug approvals and patient preferences Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB

Lung Cancer Awareness Month - Ask about a screening at your next doctor’s visit-early detection is key 🤍

Me, too! Please.